相关实验视频
Updated: Jul 25, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
12.9K
优化SERCA2a和Cx43基因对心肌梗塞并发症的共传染
Wei Wang1, Baihetiya Tayier2, Lina Guan2
1Department of Echocardiography, Xinjiang Medical University Affiliated First Hospital, Urumqi, China; Xinjiang Key Laboratory of Ultrasound Medicine, Urumqi, China; Department of Ultrasound, Urumqi Friendship Hospital, Urumqi, China.
Life sciences
|September 2, 2023
概括
代码传递SERCA2a和Cx43基因的最佳比率为1:2,显著改善了大鼠心肌梗塞 (MI) 后的心脏电生理稳定性和抗失常效应.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 再生医学是一种再生医学.
背景情况:
- 双基因疗法 (SERCA2a和Cx43) 在使用骨髓干细胞 (BMSC) 移植治疗心肌梗塞 (MI) 时显示出比单基因疗法更大的疗效.
- 研究最佳基因比例对于提高治疗结果至关重要.
研究的目的:
- 为了确定SERCA2a和Cx43基因代发的最佳比例,用于MI治疗.
- 用超声波向微泡破坏 (UTMD) 来评估不同基因比例的治疗效果.
主要方法:
- 40只老鼠接受了LAD绑定和BMSC注射.
- 通过UTMD,SERCA2a和Cx43基因以1:1,1:2和2:1的比率共同交付.
- 评估了心脏功能,心肌梗塞大小,基因表达 (SERCA2a,Cx43,Nkx2.5,GATA4) 和新血管化.
主要成果:
- 在SERCA2a/Cx43-1:2比率组显示出优越的心脏电稳定性.
- 这种最佳比率增强了MI后的抗心律失常效应.
- 基因表达和新血管化受到1:2比率的积极影响.
结论:
- 在MI治疗中,SERCA2a和Cx43基因的最佳代码传递比为1:2.
- 这种比率有利于保持心脏电生理学稳定性.
- 在MI治疗中,UTMD提供了针对性基因传递的有效方法.
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

